A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1	2024-10-15		NCT04275518

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ascentage Pharma Group Inc.	30
Suzhou Yasheng Pharmaceutical Co., Ltd.	8

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Blood Diseases Hospital Chinese Academy of Medical Sciences	Tianjin	China	2
First Hospital of Jilin University	Changchun	China	9
Guangzhou Panyu Central Hospital	Guangzhou	China	2
Henan Provincial Oncology Hospital	Zhengzhou	China	3
NanFang Hospital of Southern Medical University	Guangzhou	China	10
Shanghai Jiao Tong University school of medicine Ruijing Hospital	Shanghai	China	1
Shanghai Sixth People's Hospital	Shanghai	China	9
The First Affilated Hospital of Ganzhou Medical University	Suzhou	China	1
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The First Affiliated Hospital of Soochow University	Suzhou	China	42
The First Hospital of Peking University	Beijing	China	1
Union Hospital medical college Huazhong University of Science and Technology	Wuhan	China	3
Xiangya Hospital Central South University	Changsha	China	27
Zhongnan Hospital of Wuhan University	Wuhan	China	34